Quantcast

Latest multiple sclerosis Stories

2014-09-08 08:29:26

--Phase 2a Trial is First to Use Crowdsourcing for Protocol Design and Telemonitoring for Patient Data Collection-- NEW YORK, Sept. 8, 2014 /PRNewswire/ -- Transparency Life Sciences, LLC (TLS), the world's first clinical-stage drug development company based on open innovation, today announced that it has received a Small Business Innovation Research (SBIR) program grant to fund a Phase 2a proof-of-concept study testing the utility of the ACE inhibitor lisinopril as an adjunctive...

2014-09-04 16:27:48

FLINT, Mich., Sept. 4, 2014 /PRNewswire/ -- Diplomat, the nation's largest independent specialty pharmacy, announced that it will distribute Plegridy(TM) (peginterferon beta-1a). Manufactured by Biogen Idec, Plegridy(TM) was approved on August 15, 2014 by the US Food and Drug Administration for the treatment of relapsing forms of multiple sclerosis (RMS). Plegridy is the only pegylated beta interferon approved for use in RMS and is dosed once every two weeks. Plegridy can be...

2014-09-04 12:26:34

DIEPENBEEK, Belgium, September 4, 2014 /PRNewswire/ -- Scientists discover how to 'switch off' autoimmune diseases Apitope, the drug discovery and development company focused on disease-modifying treatments for patients with autoimmune and allergic diseases, announced today that Bristol University research led by Apitope Founder and CSO, Prof David Wraith, on its treatment approach to autoimmune diseases, such as Multiple Sclerosis (MS), has been published...

2014-09-04 04:21:59

~Crew of Sailors with MS including Bostonian Demonstrate Ability to Overcome Personal Challenges BOSTON, Sept. 4, 2014 /PRNewswire/ -- On Thursday, September 11th at 8:30 a.m., MSBoston2014 -- the world's largest international conference exclusively devoted to research in multiple sclerosis (MS) -- will host its opening ceremony with Dr. Dhib-Jalbut, President of ACTRIMS, providing an overarching look at the MS landscape. In his address, he will underscore the critical importance of MS...

2014-09-02 08:31:32

ROCKLAND, Mass., Sept. 2, 2014 /PRNewswire/ -- EMD Serono, Inc., a subsidiary of Merck KGaA, Darmstadt, Germany, announced today that Drew Young has joined the company as Senior Vice President, Neurology and Immunology. In this capacity, he will be responsible for leading the strategic direction of the U.S. Neurology and Immunology franchise, including future products. http://photos.prnewswire.com/prnvar/20140902/141784 Bringing more than 20 years of experience leading global and...

2014-08-29 23:01:01

DailyGossip.org publishes a review to the Natural Multiple Sclerosis Treatment. This is an absolutely unique method of curing multiple sclerosis in a fast and natural way. Denver, Colorado (PRWEB) August 29, 2014 DailyGossip.org publishes a review to the Natural Multiple Sclerosis Treatment. This is an absolutely unique method of curing multiple sclerosis in a fast and natural way. The new program was created by Dr. Gary M. Levin, who has become well known as a surgeon. The health...

2014-08-29 08:24:31

DUBLIN, Aug. 29, 2014 /PRNewswire/ -- Research and Markets has announced the addition of the "Global Multiple Sclerosis Drugs Market 2014-2018" report to their offering. http://photos.prnewswire.com/prnvar/20130307/600769 Multiple sclerosis is a chronic, inflammatory medical condition that results in demyelination, axonal transection, and neurodegeneration. The myelin sheath is damaged because of an abnormal response by the immune system, which targets neurons within the central nervous...

2014-08-27 08:27:25

ORLANDO, Fla, Aug. 27, 2014 /PRNewswire/ -- TNI BioTech Inc. (OTCQB: TNIB), ("we" or the "Company") a biotechnology company pioneering the manufacturing and marketing of innovative therapies for autoimmune diseases in emerging nations, today announced it had received payment and will make its first shipments of Lodonal(®) to the Republic of Panama and The Republic of Malawi in conjunction with our marketing partner, The Brewer Group, Inc. Commenting on the initial shipments, Noreen...

2014-08-25 23:00:55

A balance board accessory for a popular video game console can help people with multiple sclerosis (MS) reduce their risk of accidental falls, according to new research published online, August 26, in the journal Radiology. Magnetic resonance imaging (MRI) scans showed that use of the Nintendo Wii Balance Board system appears to induce favorable changes in brain connections associated with balance and movement. OAK BROOK, Ill. (PRWEB) August 25, 2014 A balance board accessory for a...

2014-08-21 12:26:32

NORWALK, Conn., Aug. 21, 2014 /PRNewswire/ -- UBM Medica US announces that Neurology Times, a leading online community and information resource for neurologists and other healthcare providers features special coverage on multiple sclerosis, devoted to fostering better treatment of patients who have the disorder. MS affects 2.5 million persons worldwide, including more than 400,000 Americans, and is the most common disabling neurologic disease of young adults. Although there is no cure or...


Word of the Day
malpais
  • The ragged surface of a lava-flow.
'Malpais' translates from Spanish as 'bad land.'